logo-31

Pharmacogenomics Market Use in Pharmacy Benefit Manager (PBM) Programs

The Global Pharmacogenomics Market was valued at US$ 5.58 Billion in 2024 and is expected to grow at a CAGR of 10.6% from 2024 to 2034. In 2024, North America led the market, achieving over 48.5% share with a revenue of US$ 2.7 Billion.

LinkedIn
Share
Instagram